The prognostic role of early tumor shrinkage in patients with hepatocellular carcinoma undergoing immunotherapy.

Lukas MüllerSimon Johannes GairingRoman KloecknerFriedrich FoersterEva Maria SchleicherArndt WeinmannJens MittlerFabian StoehrMoritz Christian HalfmannChristoph DüberPeter Robert GalleFelix Hahn

Published in: Cancer imaging : the official publication of the International Cancer Imaging Society (2022)

ETS was strongly associated with survival outcomes in patients with HCC undergoing immunotherapy. Thus, ETS is a readily assessable imaging biomarker that showed potential for facilitating a timely identification of patients with HCC that might benefit from immunotherapy.

Keyphrases

transcription factor
high resolution
risk assessment
human health
bioinformatics analysis